pentobarbital will minimize the extent or effect of atogepant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Proposed atogepant dosage with concomitant utilization of robust or average CYP3A4 inducers is 30 mg or sixty mg qDay.Check Intently (one)pentobarbital will minimize the extent or impact of e